Home » Topics » BioWorld Science

BioWorld Science
RSS

CytRx launches new subsidiary Centurion Biopharma

June 5, 2018

Preclinical study shows Cynata's MSCs are effective in model of diabetic ulcers

June 5, 2018

FDA grants priority review to Hemlibra sBLA

June 5, 2018

Primary efficacy endpoint not achieved in phase II study of teslexivir gel in condyloma

June 5, 2018

Yakult licenses rights to duvelisib in Japan

June 5, 2018

Perjeta approved in E.U. for adjuvant treatment of HER2-positive early breast cancer

June 5, 2018

Mabion submits MAA for rituximab biosimilar Mabion-CD20

June 5, 2018

Isomer discovery could yield countless new drugs

June 5, 2018

Clovis seeks to expand use of Rubraca in E.U. in recurrent ovarian cancer

June 5, 2018

FDA clears Nant to begin clinical trials with neoepitope yeast vaccine YE-NEO-011

June 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...